Key result
Chinese patients with Takotsubo syndrome experienced a significantly higher rate of 100-day major adverse cardiovascular and cerebrovascular events compared to patients with acute myocardial infarction (HR 1.87).
Why the study?
Takotsubo syndrome differs significantly from acute myocardial infarction in clinical features and mechanisms, but evidence in Asian populations remains limited.
Cohort (n=348)
Yes
Chinese patients with Takotsubo syndrome experience higher rates of in-hospital complications and worse short-term prognosis compared to those with acute myocardial infarction, highlighting the need for acute heart failure management in TTS.
Answers are grounded in this paper and cite their sources.
First Chinese TTS registry data suggest caution applying Western comparisons; leaves open generalizability to broader Asian populations.
Background: Takotsubo syndrome (TTS) differs significantly from acute myocardial infarction (AMI) in clinical features and pathological mechanisms, but evidence in Asian populations remains limited. The aim of this study is to compare clinical features and outcomes between patients with TTS and AMI in the first Chinese registry of TTS (ChiTTS Registry, ChiCTR1900026725). Time-to-event analysis employed Kaplan-Meier/log-rank tests with landmark analysis. Results: 8.9%, P=0.02). In comparison to AMI patients, the landmark analysis confirmed that TTS patients developed more 100-day MACCEs [hazard ratio (HR) 1.87; 95% confidence interval (CI): 1.03-3.37; log-rank test P=0.04] and all-cause mortality (HR 2.07; 95% CI: 1.10-3.91; log-rank test P=0.02). In contrast, no significant difference was found in long-term MACCEs (HR 0.38; 95% CI: 0.13-1.09; log-rank test P=0.06) and all-cause mortality (HR 0.96; 95% CI: 0.31-2.98; log-rank test P=0.94) between TTS and AMI patients. Conclusions: In comparison to AMI patients, Chinese TTS patients developed more in-hospital complications and had a worse short-term prognosis. The cardiovascular issues in TTS patients underscore the need for effective treatment and personalized strategies to enhance outcomes and mitigate risks.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2025) conducted a cohort in Takotsubo syndrome and acute myocardial infarction (n=348). Takotsubo syndrome vs. Acute myocardial infarction was evaluated on 100-day major adverse cardiovascular and cerebrovascular events (MACCEs) (HR 1.87, 95% CI 1.03-3.37, p=0.04). Chinese patients with Takotsubo syndrome experienced a significantly higher rate of 100-day major adverse cardiovascular and cerebrovascular events compared to patients with acute myocardial infarction (HR 1.87).
Synapse has enriched 10 related papers. Consider them for comparative context: